COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,652 Articles (22,913 medRxiv, 8,739 bioRxiv)

Most recent first Previous |  Page 1771: Articles 17701-17710  | Next

Site-specific steric control of SARS-CoV-2 spike glycosylation
Allen, J. D., Chawla, H., Samsudin, F., Zuzic, L., Shivgan, A. T., Watanabe, Y., He, W.-T., Callaghan, S., Song, G., Yong, P., Brouwer, P. J. M., Song, Y., Cai, Y., Duyvesteyn, H. M. E., Malinauskas, T., Kint, J., Pino, P., Wurm, M. J., Frank, M., Chen, B., Stuart, D. I., Sanders, R. W., Andrabi, R., Burton, D. R., Li, S., Bond, P. J., Crispin, M.
10.1101/2021.03.08.433764 — Posted: 2021-03-09
The FDA-approved drug cobicistat synergizes with remdesivir to inhibit SARS-CoV-2 replication
Shytaj, I. L., Fares, M., Lucic, B., Gallucci, L., Tolba, M. M., Zimmermann, L., Ayoub, A. T., Cortese, M., Neufeldt, C. J., Laketa, V., Chlanda, P., Fackler, O. T., Boulant, S., Bartenschlager, R., Stanifer, M., Savarino, A., Lusic, M.
10.1101/2021.03.09.434219 — Posted: 2021-03-09
COVIDrugNet: a network-based web tool to investigate the drugs currently in clinical trial to contrast COVID-19
Menestrina, L., Cabrelle, C., Recanatini, M.
10.1101/2021.03.05.433897 — Posted: 2021-03-09 Discussion: Onsite
A recombinant ACE2 Triple Decoy that traps and neutralizes SARS-CoV-2 shows enhanced affinity for highly transmissible SARS-CoV-2 variants
Tanaka, S., Nelson, G., Olson, A., Buzko, O., Higashide, W., Shin, A., Gonzales, M., Taft, J., Patel, R. S., Buta, S., Martin-Fernandez, M., Bogunovic, D. S., Spilman, P. R., Niazi, K., Rabizadeh, S., Soon-Shiong, P.
10.1101/2021.03.09.434641 — Posted: 2021-03-09
In vitro rapid inactivation of SARS-CoV-2 by visible light photocatalysis using boron-doped bismuth oxybromide
Ling, L., Carletti, T., Cheng, Z., Wang, R., Ren, Y., Westerhoff, P., Shang, C., Marcello, A., Chen, S.
10.1101/2021.03.09.434359 — Posted: 2021-03-09
Quantitative proteomics of hamster lung tissues infected with SARS-CoV-2 reveal host-factors having implication in the disease pathogenesis and severity
Suresh, V., Mohanty, V., Avula, K., Ghosh, A., Singh, B., Reddy, R. R. K., Suryawanshi, A. R., Raghav, S., Chattopadhyay, S., Prasad, P., Swain, R. K., Dash, R., Parida, A., Syed, G. H., Senapati, S.
10.1101/2021.03.09.434371 — Posted: 2021-03-09
Systemic Tissue and Cellular Disruption from SARS-CoV-2 Infection revealed in COVID-19 Autopsies and Spatial Omics Tissue Maps
Park, J., Foox, J., Hether, T., Danko, D., Warren, S., Kim, Y., Reeves, J., Butler, D. J., Mozsary, C., Rosiene, J., Shaiber, A., Afshinnekoo, E., MacKay, M., Bram, Y., Chandar, V., Geiger, H., Craney, A., Velu, P., Melnick, A. M., Hajirasouliha, I., Beheshti, A., Taylor, D., Saravia-Butler, A., Singh, U., Wurtele, E. S., Schisler, J., Fenessey, S., Corvelo, A., Zody, M. C., Germer, S., Salvatore, S., Levy, S., Wu, S., Tatonetti, N., Shapira, S., Salvatore, M., Loda, M., Westblade, L. F., Cushing, M., Rennert, H., Kriegel, A. J., Elemento, O., Imielinski, M., Borczuk, A. C., Meydan, C., Schwartz, R. E., Mason, C. E.
10.1101/2021.03.08.434433 — Posted: 2021-03-09
The N501Y spike substitution enhances SARS-CoV-2 transmission
Liu, Y., Liu, J., Plante, K. S., Plante, J. A., Xie, X., Zhang, X., Ku, Z., An, Z., Scharton, D., Schindewolf, C., Menachery, V. D., Shi, P.-Y., Weaver, S. C.
10.1101/2021.03.08.434499 — Posted: 2021-03-09
Spike mutations in SARS-CoV-2 variants confer resistance to antibody neutralization
Wang, R., Zhang, Q., Ge, J., Ren, W., Zhang, R., Lan, J., Ju, B., Su, B., Yu, F., Chen, P., Liao, H., Feng, Y., Li, X., Shi, X., Zhang, Z., Zhang, F., Ding, Q., Zhang, T., Wang, X., Zhang, L.
10.1101/2021.03.09.434497 — Posted: 2021-03-09
Beliefs about Mask Efficacy and the Effect of Social Norms on Mask Wearing Intentions for COVID-19 Risk Reduction
Bokemper, S. E., Cucciniello, M., Rotesi, T. E., Pin, P., Malik, A. A., Willebrand, K., Paintsil, E. E., Omer, S. B., Huber, G. A., Melegaro, A.
10.1101/2021.03.02.21252722 — Posted: 2021-03-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).